<bill session="116" type="s" number="3537" updated="2022-02-08T23:15:31Z">
  <state datetime="2020-03-19">REFERRED</state>
  <status>
    <introduced datetime="2020-03-19"/>
  </status>
  <introduced datetime="2020-03-19"/>
  <titles>
    <title type="display">Protecting Our Pharmaceutical Supply Chain from China Act of 2020</title>
    <title type="short" as="introduced">Protecting Our Pharmaceutical Supply Chain from China Act of 2020</title>
    <title type="official" as="introduced">A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001095"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2020-03-19"/>
    <cosponsor bioguide_id="C001098" joined="2020-03-19"/>
  </cosponsors>
  <actions>
    <action datetime="2020-03-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-03-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="6482" relation="identical"/>
    <bill session="116" type="s" number="3635" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Asia"/>
    <term name="Business expenses"/>
    <term name="China"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Income tax deductions"/>
    <term name="Manufacturing"/>
    <term name="Military medicine"/>
    <term name="Military procurement, research, weapons development"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Trade restrictions"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-08T19:43:59Z" status="Introduced in Senate">Protecting Our Pharmaceutical Supply Chain from China Act of 2020

This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.</summary>
</bill>
